2.50
price up icon0.00%   0.00
after-market Handel nachbörslich: 2.49 -0.010 -0.40%
loading
Schlusskurs vom Vortag:
$2.50
Offen:
$2.47
24-Stunden-Volumen:
116.62K
Relative Volume:
0.09
Marktkapitalisierung:
$56.19M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-55.99M
KGV:
-0.9995
EPS:
-2.5013
Netto-Cashflow:
$-47.60M
1W Leistung:
+0.00%
1M Leistung:
+76.06%
6M Leistung:
+95.31%
1J Leistung:
+129.36%
1-Tages-Spanne:
Value
$2.44
$2.50
1-Wochen-Bereich:
Value
$2.44
$2.60
52-Wochen-Spanne:
Value
$0.9612
$2.79

Boundless Bio Inc Stock (BOLD) Company Profile

Name
Firmenname
Boundless Bio Inc
Name
Telefon
(858) 766-9912
Name
Adresse
10955 ALEXANDRIA WAY, SAN DIEGO
Name
Mitarbeiter
28
Name
Twitter
Name
Nächster Verdiensttermin
2026-08-04
Name
Neueste SEC-Einreichungen
Name
BOLD's Discussions on Twitter

Compare BOLD vs VRTX, REGN, ARGX, ALNY, RVMD

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
BOLD icon
BOLD
Boundless Bio Inc
2.50 56.19M 0 -55.99M -47.60M -2.5013
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
522.25 134.41B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
676.23 68.13B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
919.94 57.01B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
321.59 41.79B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
190.46 40.39B 742.00K -1.37B -1.07B -7.0731

Boundless Bio Inc Stock (BOLD) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-02 Eingeleitet H.C. Wainwright Buy
2025-05-28 Herabstufung Leerink Partners Outperform → Market Perform
2024-12-13 Herabstufung Guggenheim Buy → Neutral
2024-04-22 Eingeleitet Guggenheim Buy
2024-04-22 Eingeleitet Leerink Partners Outperform
2024-04-22 Eingeleitet Piper Sandler Overweight
Alle ansehen

Boundless Bio Inc Aktie (BOLD) Neueste Nachrichten

pulisher
Jul 06, 2026

Boundless Bio to merge with Serapha Bio in reverse merger; shares surge - MSN

Jul 06, 2026
pulisher
Jul 06, 2026

Boundless Bio ten percent owner Kristina Burow sells $39,840 in stock - Investing.com

Jul 06, 2026
pulisher
Jul 06, 2026

Arch venture funds sell $39,840 in Boundless Bio stock - Investing.com

Jul 06, 2026
pulisher
Jul 06, 2026

Form 4 Boundless Bio Inc For: 6 July By Investing.com - Investing.com Canada

Jul 06, 2026
pulisher
Jul 06, 2026

ARCH funds, insiders trade 16,000 Boundless Bio (BOLD) shares - Stock Titan

Jul 06, 2026
pulisher
Jul 06, 2026

16K Boundless Bio (BOLD) shares sold by ARCH funds post-exercise - Stock Titan

Jul 06, 2026
pulisher
Jul 06, 2026

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Jul 06, 2026
pulisher
Jul 03, 2026

TANG CAPITAL MANAGEMENT LLC Acquires Significant Stake in Boundless Bio Inc - GuruFocus

Jul 03, 2026
pulisher
Jul 02, 2026

Major Investor Doubles Down on Boundless Bio With Bold New Stock Purchase - TipRanks

Jul 02, 2026
pulisher
Jul 02, 2026

Kevin Tang buys $268,880 of Boundless Bio (NASDAQ:BOLD) shares - Investing.com

Jul 02, 2026
pulisher
Jul 02, 2026

Form 4 Boundless Bio Inc For: 2 July By Investing.com - Investing.com UK

Jul 02, 2026
pulisher
Jul 02, 2026

Boundless Bio (BOLD) major holder buys 107,463 Common shares - Stock Titan

Jul 02, 2026
pulisher
Jul 02, 2026

SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--ACA, APGE, BOLD, and GBCS - Sahm

Jul 02, 2026
pulisher
Jun 29, 2026

Major Investor Makes Bold Move on Boundless Bio Shares - TipRanks

Jun 29, 2026
pulisher
Jun 29, 2026

Tang Capital Management acquires $714,768 of Boundless Bio stock - Investing.com

Jun 29, 2026
pulisher
Jun 29, 2026

Tang Capital Management acquires $714,768 of Boundless Bio stock By Investing.com - Investing.com Nigeria

Jun 29, 2026
pulisher
Jun 29, 2026

Form 4 Boundless Bio Inc For: 29 June By Investing.com - Investing.com India

Jun 29, 2026
pulisher
Jun 29, 2026

Tang-linked entities report 11.3% stake in Boundless Bio (NASDAQ: BOLD) - Stock Titan

Jun 29, 2026
pulisher
Jun 29, 2026

Tang Capital-affiliated funds boost Boundless Bio (BOLD) stake with 286K-share buy - Stock Titan

Jun 29, 2026
pulisher
Jun 29, 2026

Tang Capital entities disclose 2.25M Boundless Bio (BOLD) shares in Form 3 filing - Stock Titan

Jun 29, 2026
pulisher
Jun 29, 2026

Enterprise value to revenue forward of Boundless Bio, Inc. – NASDAQ:BOLD - TradingView

Jun 29, 2026
pulisher
Jun 29, 2026

Enterprise value to EBITDA forward of Boundless Bio, Inc. – NASDAQ:BOLD - TradingView

Jun 29, 2026
pulisher
Jun 29, 2026

Price to sales forward of Boundless Bio, Inc. – NASDAQ:BOLD - TradingView

Jun 29, 2026
pulisher
Jun 26, 2026

Boundless Bio Inc. Actuals & Estimates (NASDAQ:BOLD) - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

BOLD Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026
pulisher
Jun 25, 2026

Are TECH, APGE, BOLD, REFI Obtaining Fair Deals for their Shareholders? - TradingView

Jun 25, 2026
pulisher
Jun 24, 2026

Crude Oil Down Over 1%; US Manufacturing PMI Surges In June - Sahm

Jun 24, 2026
pulisher
Jun 24, 2026

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Sahm

Jun 24, 2026
pulisher
Jun 24, 2026

Dow Falls Over 300 Points; Korn Ferry Earnings Top Views - Sahm

Jun 24, 2026
pulisher
Jun 23, 2026

NewCo Serapha taking path to NASDAQ via merger with Boundless: Deals Report - biocentury.com

Jun 23, 2026
pulisher
Jun 23, 2026

$Boundless Bio (BOLD.US)$ - Moomoo

Jun 23, 2026
pulisher
Jun 23, 2026

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Boundless Bio, Inc. (NASDAQ: BOLD) - PR Newswire

Jun 23, 2026
pulisher
Jun 23, 2026

Serapha Bio takes flight from Boundless merger with $230M and gene-editing prospect from China - Fierce Biotech

Jun 23, 2026
pulisher
Jun 23, 2026

Form 8K Boundless Bio Inc For: 23 June By Investing.com - Investing.com South Africa

Jun 23, 2026
pulisher
Jun 23, 2026

Boundless Bio and Serapha Bio to merge - The Pharma Letter

Jun 23, 2026
pulisher
Jun 23, 2026

BOLD Stock Alert: Halper Sadeh LLC is Investigating Whether Boundless Bio, Inc. is Obtaining a Fair Price for its Shareholders - Business Wire

Jun 23, 2026
pulisher
Jun 23, 2026

Boundless Bio's reverse merger; CARsgen wins first solid tumor approval for CAR-T - Endpoints News

Jun 23, 2026
pulisher
Jun 23, 2026

Boundless Bio Inc. (BOLD) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Jun 23, 2026
pulisher
Jun 23, 2026

The market is filled with gapping stocks in Tuesday's session. - ChartMill

Jun 23, 2026
pulisher
Jun 23, 2026

Boundless Bio to Merge with Serapha Bio, Restructure Operations - TipRanks

Jun 23, 2026
pulisher
Jun 23, 2026

BOLD Stock Pops As Traders Target Volatile Bounce - StocksToTrade

Jun 23, 2026
pulisher
Jun 23, 2026

BOLD: All-stock merger creates a focused gene editing company targeting AATD with strong financial runway - TradingView

Jun 23, 2026
pulisher
Jun 23, 2026

BOLD: All-stock merger creates a gene-editing leader targeting AATD, with Boundless shareholders receiving a cash dividend - TradingView

Jun 23, 2026
pulisher
Jun 23, 2026

US market outlook: Semiconductors and large-cap stocks decline amid concerns over US rate hikes and rising procurement costs; SoFi acquires Composer to bolster AI-driven trading; Boundless Bio shares surge on merger announcement with Seraffa - Moomoo

Jun 23, 2026
pulisher
Jun 23, 2026

BOLD Stock Grinds Sideways As Traders Eye Cash Runway - timothysykes.com

Jun 23, 2026
pulisher
Jun 23, 2026

Boundless Bio stock surges on Serapha Bio merger agreement By Investing.com - Investing.com Australia

Jun 23, 2026
pulisher
Jun 23, 2026

Boundless Bio stock surges on Serapha Bio merger agreement - Investing.com

Jun 23, 2026
pulisher
Jun 23, 2026

Boundless Bio (BOLD) to merge with Serapha after $230M+ financings; 75% workforce cut - Stock Titan

Jun 23, 2026
pulisher
Jun 23, 2026

Serapha Bio to take control of Boundless Bio (NASDAQ: BOLD) in cash-dividend merger - Stock Titan

Jun 23, 2026
pulisher
Jun 23, 2026

What's going on in today's pre-market session - ChartMill

Jun 23, 2026
pulisher
Jun 23, 2026

Boundless Bio Agrees To Merge With Serapha Bio - Finimize

Jun 23, 2026

Finanzdaten der Boundless Bio Inc-Aktie (BOLD)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Boundless Bio Inc-Aktie (BOLD) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
CRANDELL KEITH
10% Owner
Jul 01 '26
Sale
2.49
16,000
39,840
0
ARCH Venture Fund IX, L.P.
10% Owner
Jul 01 '26
Option Exercise
1.03
16,000
16,480
16,000
ARCH Venture Fund IX, L.P.
10% Owner
Jul 01 '26
Sale
2.49
16,000
39,840
0
TANG KEVIN
10% Owner
Jul 01 '26
Buy
2.49
71,612
178,314
2,631,487
TANG KEVIN
10% Owner
Jun 30 '26
Buy
2.54
26,030
66,112
2,559,875
TANG KEVIN
10% Owner
Jul 02 '26
Buy
2.49
9,821
24,454
2,641,308
$112.84
price up icon 1.17%
$57.80
price up icon 1.55%
$36.31
price up icon 2.60%
$79.77
price down icon 2.48%
ONC ONC
$308.96
price down icon 0.16%
$190.46
price up icon 0.25%
Kapitalisierung:     |  Volumen (24h):